Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OraSure Technologies, Inc. - Common Stock (NQ:OSUR)

2.525 -0.075 (-2.88%)
Streaming Delayed Price Updated: 1:53 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OraSure Technologies, Inc. - Common Stock

< Previous 1 2 Next >
OraSure Announces First Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Announces $40 Million Stock Repurchase Program
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Fourth Quarter 2024 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Present at the J.P Morgan Healthcare Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
From OraSure Technologies, Inc.
Via GlobeNewswire
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Acquires Sherlock Biosciences
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Participate in Upcoming Investor Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q3 ’24 Revenue of $39.9 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Elects Jack Kenny to the Board of Directors
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q2 ’24 Revenue of $54.3 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Supports National HIV Testing Day
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q1 ’24 Revenue of $54.1 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Participate in Upcoming Investor Conferences
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Second Quarter 2023 Financial Results and Host Earnings Call on August 3rd
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Elects Robert McMahon to the Board of Directors
From OraSure Technologies, Inc.
Via GlobeNewswire
Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access
From OraSure Technologies, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.